Sutro Biopharma, Inc.: Form 8-K, filed Jun 17, 2021
Filed with the SEC on Jun 17, 2021 and accepted by EDGAR at Jun 17, 2021, 17:29 ET.
Items reported
- Item 1.01 Entry into a material agreement
- Item 2.03 New direct financial obligation
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001564590-21-033400. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.